Evidencia científica
Explore investigaciones revisadas por pares y estudios clínicos que respaldan las aplicaciones de la enfoque de medicina regenerativa en diversas condiciones médicas.
Research at a Glance
Key metrics from over a decade of regenerative medicine approach research (2015-2025)
116+
Clinical Trials with Regulatory Approval
1,138+
Registered MSC Clinical Trials (2020)
255+
MSC Trials for Neurological Diseases
Zero
Tumors in 217-Study Safety Analysis
A Decade of Scientific Progress
The field of regenerative medicine has experienced unprecedented growth over the past decade. From 2015 to 2025, researchers worldwide have conducted thousands of clinical trials, published groundbreaking studies, and developed innovative therapeutic approaches using stem cells and their derivatives.
Our commitment to evidence-based medicine means we continuously monitor and incorporate the latest peer-reviewed research from prestigious journals including Nature, The Lancet, Cell Stem Cell, and other leading publications.
Trusted Sources
Research from Nature, Lancet, Cell, Frontiers, PubMed, and more
Rigorous Methodology
Systematic reviews, meta-analyses, and randomized controlled trials
Continuous Updates
Regular monitoring of latest research developments and clinical outcomes
255+ clinical trials for conditions including Parkinson's, Alzheimer's, stroke, spinal cord injury, multiple sclerosis, and ALS.
Source: PMC, Cell Stem Cell, Frontiers in Medicine
Meta-analysis of 28 RCTs with 1,494 participants showing significant pain reduction and improved joint function in osteoarthritis.
Source: PMC Systematic Review (2022)
Multiple trials demonstrating reduced scar tissue, increased angiogenesis, and improved cardiac function post-MI.
Source: Stem Cell Research & Therapy, MDPI
Phase III trial (Cx601) showed 50% remission for Crohn's disease perianal fistulas, sustained at 56.3% at 52 weeks.
Source: The Lancet, Nature STTT
Established Safety Record
A decade of clinical research has consistently demonstrated the safety of mesenchymal stem cell therapies
Zero Tumor Formation
Systematic review of 217 studies found no tumors from injected MSCs and no increased tumorigenesis in host tissues.
1,138+ Trials Documented
By 2020, over 1,138 registered clinical trials with no serious adverse events reported across all indications.
Low Immunogenicity
MSCs demonstrate low immunogenic profile, reducing rejection risk. MSC-derived exosomes show even lower immunogenicity.
Our Commitment to Ethics, Safety & Regulatory Compliance
At StemCell Longevita, we operate under the highest standards of medical ethics, GMP manufacturing, and regulatory compliance — setting us apart from unregulated providers.
GMP-Certified Laboratory
Our stem cells are processed in a Good Manufacturing Practice (GMP) certified laboratory, meeting the same pharmaceutical-grade standards required for drug manufacturing. This includes sterile clean-room environments, validated processes, and rigorous quality control at every step.
- ISO-classified clean rooms
- Batch-level cell viability testing
- Full chain-of-custody documentation
- Sterility & endotoxin screening
Ethical Wharton's Jelly Sourcing
Our mesenchymal stem cells are derived exclusively from Wharton's jelly — the connective tissue within the umbilical cord — collected after healthy, full-term births with full informed consent from donors. This approach is ethically uncontroversial and yields young, highly potent cells.
- Informed consent from all donors
- Non-invasive collection after birth
- Comprehensive donor screening
- No embryonic tissue used
Regulatory & Hospital Framework
All procedures are performed within JCI-accredited Liv Hospital Ulus under the supervision of Prof. Dr. Erdal Karaöz. We operate within Turkish Ministry of Health regulations for advanced therapy medicinal products and adhere to international clinical guidelines. These approaches remain under ongoing scientific research and clinical evaluation.
- JCI-accredited hospital facility
- Turkish Ministry of Health oversight
- Professor-led medical team
- Published clinical outcomes
Transparency & Evidence-Based Practice
We believe patients deserve full transparency about what stem cell approaches can and cannot do. Our methodology is grounded in published peer-reviewed evidence and ongoing scientific research. We do not make unsubstantiated claims about cure rates, and we provide realistic expectations during every consultation. Every study referenced on this page is independently verifiable through the linked source. Individual results may vary and are not guaranteed.
Publicaciones revisadas por pares
Access summaries and direct links to peer-reviewed research from leading scientific journals worldwide
Pluripotent Stem-Cell-Derived Therapies in Clinical Trial: A 2025 Update
Cell Stem Cell (2025) - Kimbrel EA, Lanza R
Comprehensive review identifying 116 clinical trials with regulatory approval testing 83 human pluripotent stem cell products. Eye diseases, CNS disorders, and cancer are leading indications.
Ver estudioMesenchymal Stem Cells in Treating Human Diseases: Molecular Mechanisms and Clinical Studies
Nature Signal Transduction and Targeted Therapy (2025) - Multiple authors
Landmark review covering MSC molecular mechanisms. References Phase III Cx601 trial showing 50% remission vs. 34% placebo for Crohn's perianal fistulas at 24 weeks.
Ver estudioCurrent State of Stem Cell-Based Therapies: An Overview
PubMed Central (PMC) (2020) - Zakrzewski W, et al.
Foundational overview of stem cell therapies covering types, mechanisms, and applications across multiple disease categories. Referenced by over 1,000 subsequent studies.
Ver estudioStem Cell Therapies for Neurological Disorders: Current Progress, Challenges, and Future Perspectives
European Journal of Medical Research (2024) - Multiple authors
Documents 255+ MSC clinical trials for neurological diseases including 38 for spinal cord injury, 27 for stroke, and 25 for ALS.
Ver estudioAdvances in Clinical Translation of Stem Cell-Based Therapy in Neurological Diseases
PubMed Central (PMC) (2025) - Multiple authors
Latest advances in translating stem cell research into clinical applications for neurological conditions, covering multiple Phase I-III trials.
Ver estudioSafety and Efficacy of Mesenchymal Stem Cells in Severe/Critical COVID-19: A Systematic Review and Meta-Analysis
The Lancet eClinicalMedicine (2022) - Multiple authors
Systematic review finding stem cell therapy showed remarkable effect in reducing mortality and morbidity in severe COVID-19 patients.
Ver estudioThe Effectiveness and Safety of Mesenchymal Stem Cells in the Treatment of Osteoarthritis: A Systematic Review and Meta-analysis of 28 RCTs
PubMed Central (PMC) (2022) - Multiple authors
Meta-analysis of 28 randomized controlled trials with 1,494 participants showing MSCs reduced WOMAC pain scores at 3-month follow-up.
Ver estudioClinical Progress in Mesenchymal Stem Cell Therapy: A Focus on Rheumatic Diseases
PubMed Central (PMC) (2024) - Multiple authors
Covers MSC applications in SLE, rheumatoid arthritis, ankylosing spondylitis, and fibromyalgia with immunomodulatory and regenerative properties.
Ver estudioMesenchymal Stem Cell Treatment Does Not Result in Tumor Formation: A Systematic Review
Herald Scholarly Open Access (2023) - Multiple authors
Analysis of 217 studies confirming zero tumors from injected MSCs and no increased tumorigenesis in host tissues.
Ver estudioMesenchymal Stem Cells for Lung Diseases: Focus on Immunomodulatory Action
Nature Cell Death Discovery (2025) - Multiple authors
Focus on MSC therapy for inflammatory lung diseases, highlighting anti-inflammatory and anti-apoptotic properties.
Ver estudioMesenchymal Stem Cell-Derived Extracellular Vesicles for Immunomodulation and Regeneration
Nature Cell Death & Disease (2022) - Multiple authors
Focus on MSC-derived extracellular vesicles (EVs) advantages including lower immunogenicity compared to direct cell therapy.
Ver estudioTherapeutic Potential of Mesenchymal Stem Cells in Stroke Treatment
MDPI Biomolecules (2025) - Multiple authors
Explores MSC mechanisms for stroke recovery including neuroregeneration, angiogenesis, and neuroprotection in 27 registered clinical trials.
Ver estudioNeural Stem Cells in Adult Neurogenesis and Therapeutic Applications in Neurodegenerative Disorders
Frontiers in Molecular Medicine (2025) - Multiple authors
Comprehensive review of neural stem cells for treating Parkinson's, Alzheimer's, and other neurodegenerative conditions.
Ver estudioStem Cell Therapy Offers New Hope for the Treatment of Alzheimer's Disease
Frontiers in Cell and Developmental Biology (2025) - Multiple authors
Details how MSCs reduce amyloid-β deposition, attenuate neuroinflammation, and promote neurogenesis in Alzheimer's disease.
Ver estudioThe Potential of Exosomes in Regenerative Medicine and in the Diagnosis and Therapies of Neurodegenerative Diseases and Cancer
Frontiers in Medicine / PMC (2025) - Multiple authors
Analysis of 90 clinical trials showing exosomes used as biomarkers and therapeutic agents, with 21% exploring therapeutic roles.
Ver estudioThe Future of Osteoarthritis Treatment: Exploring the Potential of Exosomes from Adipose Tissue-Derived Stem Cells
PubMed Central (PMC) (2025) - Multiple authors
Scoping review on ADSC-exosomes showing anti-inflammatory effects and promotion of cartilage regeneration via miRNA transport.
Ver estudioTherapeutic Potential of Stem Cell-Derived Exosomes in Hair Regeneration: A Systematic Review
PubMed Central (PMC) (2025) - Multiple authors
Analysis of 27 studies showing exosomes modulate signaling pathways, enhance follicle regeneration, and treat alopecia areata.
Ver estudioEmerging Regenerative Strategies for Spinal Cord Injury: Exosome-Derived Mechanisms and Therapeutic Insights
PubMed Central (PMC) (2025) - Multiple authors
Explores exosomes as drug delivery carriers with targeting capabilities and nerve regeneration properties for spinal cord injuries.
Ver estudioEfficacy and Safety of Stem Cell Therapy in Children With Autism Spectrum Disorders: A Systematic Review and Meta-Analysis
Frontiers in Pediatrics / PMC (2022) - Multiple authors
Meta-analysis of 5 studies showing stem cell groups had significantly lower CARS scores than controls (WMD: −5.96, p < 0.0001).
Ver estudioEfficacy and Safety of Stem Cell Therapy in Cerebral Palsy: A Systematic Review and Meta-Analysis
Frontiers in Bioengineering and Biotechnology (2022) - Multiple authors
Comprehensive review showing consistent motor improvements and strong safety profile across multiple cell types for cerebral palsy.
Ver estudioProgress in Clinical Trials of Stem Cell Therapy for Cerebral Palsy
PubMed Central (PMC) (2021) - Multiple authors
Documents clinical trial landscape for CP showing improvements in Gross Motor Function Measure (GMFM) and quality of life.
Ver estudioClinical Application of Mesenchymal Stem Cell in Regenerative Medicine: A Narrative Review
Stem Cell Research & Therapy (2022) - Multiple authors
Comprehensive narrative review covering MSC applications across cardiovascular, neurological, orthopedic, and autoimmune conditions.
Ver estudioMesenchymal Stem Cells Current Clinical Applications: A Systematic Review
Archives of Medical Research (ScienceDirect) (2021) - Multiple authors
By July 2020, documented 1,138 registered clinical trials with no serious adverse events reported across all indications.
Ver estudioA Brief Overview of Global Trends in MSC-Based Cell Therapy
Stem Cell Reviews and Reports (2022) - Multiple authors
Analysis of global trends in MSC therapy development, regulatory landscape, and clinical trial distribution worldwide.
Ver estudioRevolutionizing Medicine: Recent Developments and Future Prospects in Stem-Cell Therapy
PubMed Central (PMC) (2024) - Multiple authors
Overview of latest developments in stem cell therapy including gene editing, exosome-based therapies, and precision medicine approaches.
Ver estudioOverview of Cellular Therapeutics Clinical Trials: Advances, Challenges, and Future Directions
MDPI International Journal of Molecular Sciences (2025) - Multiple authors
Comprehensive overview of cellular therapeutics trials covering advances in manufacturing, delivery, and clinical outcomes.
Ver estudioClinical Trials Test the Safety of Stem-Cell Therapy for Parkinson's Disease
Nature (2025) - Nature News
Coverage of first-in-human studies for Parkinson's disease using stem cell-derived dopamine neurons, confirming safety profiles.
Ver estudioTrends in Mesenchymal Stem Cell-Derived Extracellular Vesicles Clinical Trials 2014-2024
Frontiers in Medicine (2025) - Multiple authors
Analysis of MSC-EV clinical trials exploring optimal dosing strategies and therapeutic applications across various conditions.
Ver estudioCell Therapy Approaches to Autism: A Review of Clinical Trial Data
Molecular Autism (2020) - Multiple authors
Review of cell therapy clinical trials for autism, analyzing methodologies, outcomes, and future research directions.
Ver estudioStem Cells Therapy in Neurodegenerative and Neuroimmune Diseases: Current Status and Future Prospects
ScienceDirect (2025) - Multiple authors
Comprehensive coverage of stem cell applications in MS, ALS, and other neuroimmune conditions with latest clinical trial data.
Ver estudioLeading Scientific Journals
Our research references are sourced from the world's most prestigious peer-reviewed scientific publications
Nature
Preeminent international scientific journal
The Lancet
Leading general medical journal
Cell Stem Cell
Premier stem cell research journal
PubMed/PMC
NIH biomedical literature database
Frontiers
Open-access scientific publisher
MDPI
Multidisciplinary scientific publisher
ScienceDirect
Elsevier's research database
Springer Nature
Global research publisher